共 86 条
[1]
Rooman I(2002)Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue Diabetes 51 686-690
[2]
Lardon J(2002)Evidence for early impairment of glucagon-like peptide 1-induced insulin secretion in human type 2 (non insulin-dependent) diabetes Horm Metab Res 34 150-154
[3]
Bouwens L(1999)Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion Eur J Gastroenterol Hepatol 11 1277-1282
[4]
Lugari R(2004)Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan Diabetologia 47 259-265
[5]
Dei Cas A(2009)Proton pump inhibitors as a treatment method for type II diabetes Med Hypothesis 73 29-32
[6]
Ugolotti D(2012)Proton pump inhibitor therapy associated with lower glycosylated hemoglobin levels in type 2 diabetes J Am Board Fam Med 25 50-54
[7]
Finardi L(2012)Improved diabetes control and pancreatic function in a type 2 diabetic after omeprazole administration Case Rep Endocrinol 2012 468609-E2108
[8]
Barilli AL(2012)Pantoprazole improves glycemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled trial J Clin Endocrinol Metab 97 E2105-1495
[9]
Ognibene C(2004)Use and abuse of HOMA modeling Diabetes Care 27 1487-65
[10]
Luciani A(2005)Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod Aliment Pharmacol Ther 22 59-2440